Lista de obras -

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

artículo científico publicado en 2015

BI-32RISK FACTOR ANALYSIS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WHO DID NOT RECEIVE SALVAGE THERAPY.

artículo científico publicado en 2014

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

scientific article published on 08 July 2020

Carbon fiber-reinforced PEEK versus titanium implants: an in vitro comparison of susceptibility artifacts in CT and MR imaging

scientific article published on 15 September 2020

Chemotherapy for intracranial ependymoma in adults

artículo científico publicado en 2016

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases

artículo científico publicado en 2017

Clonality of circulating tumor cells in breast cancer brain metastasis patients

scientific article published on 03 September 2019

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

artículo científico publicado en 2017

DNA methylation-based classification of central nervous system tumours

artículo científico publicado en 2018

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment

artículo científico publicado en 2018

DRES-12. SINGLE CELL CLONAL ANALYSIS OF GBM TUMOR HIERARCHIES USING OPTICAL BARCODING

artículo científico publicado en 2017

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

artículo científico publicado en 2020

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

scientific article published on 05 September 2018

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

scientific article published on 15 May 2019

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.

artículo científico publicado en 2017

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

artículo científico publicado en 2018

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

artículo científico publicado en 2016

Glioma escape signature and clonal development under immune pressure

artículo científico publicado en 2020

Hematogenous dissemination of glioblastoma multiforme.

artículo científico publicado en 2014

IMMU-44. OPTICAL BARCODING TO INVESTIGATE CLONAL DYNAMICS OF GBM HIGHLIGHTS THE INTRINSIC CAPACITY OF GBM TO RE-ACTIVATE DEVELOPMENTAL GENES AND ESCAPE IMMUNE SURVEILLANCE

artículo científico publicado en 2018

IMMU-55. IMMUNOMODULATORY IL-7 AND IL-12-EXPRESSING MSCs INDUCE LONG-TERM SURVIVAL AND IMMUNITY IN SYNGENEIC INTRACEREBRAL GLIOBLASTOMA MODELS

IMMU-62. OPTICAL BARCODING REVEALS IMMUNOEDITING OF THE CLONAL ARCHITECTURE AND MODULATION OF GENE EXPRESSION SIGNATURES IN A SYNGENEIC GLIOMA MODEL

Identification of HERC5 and its potential role in NSCLC progression

artículo científico publicado en 2014

Immune Characterization in Aneurysmal Subarachnoid Hemorrhage Reveals Distinct Monocytic Activation and Chemokine Patterns

artículo científico publicado en 2019

Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas

scientific article published on 02 July 2019

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes

artículo científico publicado en 2018

Irreversible Total Loss of Brain Function and Organ Donation in Patients with Aneurysmal Subarachnoid Hemorrhage

artículo científico publicado en 2017

Keyhole approaches to intradural pathologies.

artículo científico publicado en 2017

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma

artículo científico publicado en 2017

Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma

scientific article published on 27 January 2020

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

artículo científico publicado en 2014

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

artículo científico publicado en 2015

Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape

artículo científico publicado en 2020

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity

artículo científico publicado en 2017

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

artículo científico publicado en 2010

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

artículo científico publicado en 2012

Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

artículo científico publicado en 2015

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

artículo científico publicado en 2013

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

artículo científico publicado en 2016

Rate and risk factors for a hyperactivity delirium in patients with aneurysmal subarachnoid haemorrhage

artículo científico publicado en 2018

Secretory Meningiomas: Characteristic Features and Clinical Management of a Unique Subgroup.

artículo científico publicado en 2016

Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype.

artículo científico publicado en 2016

Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.

artículo científico publicado en 2018

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade

artículo científico publicado en 2016

Lista de obras de

Adult IDH wild type astrocytomas biologically and clinically resolve into other tumor entities

BI-32RISK FACTOR ANALYSIS FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA WHO DID NOT RECEIVE SALVAGE THERAPY.

CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas

Carbon fiber-reinforced PEEK versus titanium implants: an in vitro comparison of susceptibility artifacts in CT and MR imaging

Chemotherapy for intracranial ependymoma in adults

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases

Clonality of circulating tumor cells in breast cancer brain metastasis patients

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis

DNA methylation-based classification of central nervous system tumours

DNA methylation-based classification of ependymomas in adulthood: implications for diagnosis and treatment

DRES-12. SINGLE CELL CLONAL ANALYSIS OF GBM TUMOR HIERARCHIES USING OPTICAL BARCODING

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay

Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

EGFR as a Target for Glioblastoma Treatment: An Unfulfilled Promise.

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

Gene-Tailored Treatments for Brain Disorders: Challenges and Opportunities

Glioma escape signature and clonal development under immune pressure

Hematogenous dissemination of glioblastoma multiforme.

IMMU-44. OPTICAL BARCODING TO INVESTIGATE CLONAL DYNAMICS OF GBM HIGHLIGHTS THE INTRINSIC CAPACITY OF GBM TO RE-ACTIVATE DEVELOPMENTAL GENES AND ESCAPE IMMUNE SURVEILLANCE

IMMU-55. IMMUNOMODULATORY IL-7 AND IL-12-EXPRESSING MSCs INDUCE LONG-TERM SURVIVAL AND IMMUNITY IN SYNGENEIC INTRACEREBRAL GLIOBLASTOMA MODELS

IMMU-62. OPTICAL BARCODING REVEALS IMMUNOEDITING OF THE CLONAL ARCHITECTURE AND MODULATION OF GENE EXPRESSION SIGNATURES IN A SYNGENEIC GLIOMA MODEL

Identification of HERC5 and its potential role in NSCLC progression

Immune Characterization in Aneurysmal Subarachnoid Hemorrhage Reveals Distinct Monocytic Activation and Chemokine Patterns

Immunologic Profiling of Mutational and Transcriptional Subgroups in Pediatric and Adult High-Grade Gliomas

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes

Irreversible Total Loss of Brain Function and Organ Donation in Patients with Aneurysmal Subarachnoid Hemorrhage

Keyhole approaches to intradural pathologies.

Limited role for extended maintenance temozolomide for newly diagnosed glioblastoma

Local Intracerebral Immunomodulation Using Interleukin-Expressing Mesenchymal Stem Cells in Glioblastoma

Molecular characterization of long-term survivors of glioblastoma using genome- and transcriptome-wide profiling.

Molecular classification of diffuse cerebral WHO grade II/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups

Molecular profiling of an osseous metastasis in glioblastoma during checkpoint inhibition: potential mechanisms of immune escape

Optical Barcoding for Single-Clone Tracking to Study Tumor Heterogeneity

Patients with IDH1 wild type anaplastic astrocytomas exhibit worse prognosis than IDH1-mutated glioblastomas, and IDH1 mutation status accounts for the unfavorable prognostic effect of higher age: implications for classification of gliomas

Predictive impact of MGMT promoter methylation in glioblastoma of the elderly

Printed peptide arrays identify prognostic TNC serumantibodies in glioblastoma patients

Prognostic or predictive value of MGMT promoter methylation in gliomas depends on IDH1 mutation

Prognostic relevance of miRNA-155 methylation in anaplastic glioma

Rate and risk factors for a hyperactivity delirium in patients with aneurysmal subarachnoid haemorrhage

Secretory Meningiomas: Characteristic Features and Clinical Management of a Unique Subgroup.

Secretory Meningiomas: Increased Prevalence of Seizures Secondary to Edema Formation in a Rare Histologic Subtype.

Tectal gliomas: assessment of malignant progression, clinical management, and quality of life in a supposedly benign neoplasm.

Transcriptomic analysis of aggressive meningiomas identifies PTTG1 and LEPR as prognostic biomarkers independent of WHO grade